<!-- Generated by pkgdown: do not edit by hand -->
<!DOCTYPE html>
<html lang="en">
  <head>
  <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>gsdmvn: A package for group sequential design under non-proportional hazards (NPH) — gsdmvn • gsdmvn</title>


<!-- jquery -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
<!-- Bootstrap -->

<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous" />

<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script>

<!-- bootstrap-toc -->
<link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script>

<!-- Font Awesome icons -->
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous" />
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous" />

<!-- clipboard.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script>

<!-- headroom.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script>

<!-- pkgdown -->
<link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script>



  <link href="../extra.css" rel="stylesheet">
  

<meta property="og:title" content="gsdmvn: A package for group sequential design under non-proportional hazards (NPH) — gsdmvn" />
<meta property="og:description" content="The gsdmvn package will eventually be incorporated into the gsDesign2 package.
This version is for the Regulatory/ASA Biopharmaceutical Subsection training course in September, 2020
The package computes the asymptotic normal distribution for group sequential designs,
generalizing the theory presented by Jennison and Turnbull (2000) to cases with
non-homogeneous treatment effect over time.
The primary application for this is group sequential design under the assumption of non-proportional hazards.
The gsdmvn package has 4 types of functions
1) support for asymptotic normal distribution computation,
2) support for group sequential bound derivation, and
3) support for design and power calculations.
4) applications to designs for survival analysis under non-proportional hazards assumptions." />




<!-- mathjax -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script>

<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->



  </head>

  <body data-spy="scroll" data-target="#toc">
    <div class="container template-reference-topic">
      <header>
      <div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">gsdmvn</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Released version">0.1.1.9000</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="../index.html">
    <span class="fas fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Articles
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="../articles/DesignWithAverageHazardRatio.html">Design Using Average Hazard Ratio</a>
    </li>
    <li>
      <a href="../articles/DesignWithSpending.html">Trial design with spending under NPH</a>
    </li>
    <li>
      <a href="../articles/NPEbackground.html">Non-Proportional Effect Size in Group Sequential Design</a>
    </li>
    <li>
      <a href="../articles/NPEbounds.html">Computing Bounds Under Non-Constant Treatment Effect</a>
    </li>
    <li>
      <a href="../articles/PowerEvaluationWithSpending.html">Power Evaluation with Spending bounds</a>
    </li>
    <li>
      <a href="../articles/QuickStart.html">Quick Start for NPH Sample Size and Power</a>
    </li>
    <li>
      <a href="../articles/SpendingTimeExamples.html">Spending Time Examples</a>
    </li>
  </ul>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.com/Merck/gsdmvn/">
    <span class="fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
      
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header>

<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>gsdmvn: A package for group sequential design under non-proportional hazards (NPH)</h1>
    <small class="dont-index">Source: <a href='https://github.com/Merck/gsdmvn/blob/master/R/gsdmvn.r'><code>R/gsdmvn.r</code></a></small>
    <div class="hidden name"><code>gsdmvn.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>The gsdmvn package will eventually be incorporated into the gsDesign2 package.
This version is for the Regulatory/ASA Biopharmaceutical Subsection training course in September, 2020
The package computes the asymptotic normal distribution for group sequential designs,
generalizing the theory presented by Jennison and Turnbull (2000) to cases with
non-homogeneous treatment effect over time.
The primary application for this is group sequential design under the assumption of non-proportional hazards.
The gsdmvn package has 4 types of functions
1) support for asymptotic normal distribution computation,
2) support for group sequential bound derivation, and
3) support for design and power calculations.
4) applications to designs for survival analysis under non-proportional hazards assumptions.</p>
    </div>



    <h2 class="hasAnchor" id="details"><a class="anchor" href="#details"></a>Details</h2>

    <p>In addition to the above function categeories, vignettes show how to implement
1) design for a binomial endpoint as an example of how to extend the package to other endpoint types,
2) the extensive capabilities around group sequential boundary calculations,
including enabling capabilities not in the gsDesign package.</p>
    <h2 class="hasAnchor" id="gsdmvn-functions"><a class="anchor" href="#gsdmvn-functions"></a>gsdmvn functions</h2>

    

<p>The primary functions supporting non-proportional hazards in the short course are:</p><ul>
<li><p>gs_design_ahr - derive group sequential design under non-proportional hazards (NPH) for logrank test</p></li>
<li><p>gs_power_ahr - compute power for a group sequential design under non-proportional hazards for logrank test</p></li>
</ul>

<p>Key supportive functions specify bound derivation for designs:</p><ul>
<li><p>gs_b - directly provide bounds for designs</p></li>
<li><p>gs_spending_bound - provide bounds based on a spending function (e.g., Lan-DeMets O'Brien-Fleming)</p></li>
</ul>

<p>Underlying functions to support numerical integration that should not be directly needed by typical users are</p><ul>
<li><p>gridpts - set up grid points and weights for numerical integration for a normal distribution</p></li>
<li><p>h1 - initialize numerical integration grid points and weights for NPH for first analysis</p></li>
<li><p>hupdate - update numerical integration grid points and weights for NPH from one interim to the next</p></li>
<li><p>gs_power_npe - general non-constant-effect size boundary crossing probability calculation for group sequential design</p></li>
</ul>

    <h2 class="hasAnchor" id="references"><a class="anchor" href="#references"></a>References</h2>

    <p>Jennison C and Turnbull BW (2000), <em>Group Sequential
Methods with Applications to Clinical Trials</em>. Boca Raton: Chapman and Hall.</p>
    <h2 class="hasAnchor" id="author"><a class="anchor" href="#author"></a>Author</h2>

    <p>Keaven Anderson <a href='mailto:keaven\_anderson@merck.'>keaven\_anderson@merck.</a></p>

  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top">
      <h2 data-toc-skip>Contents</h2>
    </nav>
  </div>
</div>


      <footer>
      <div class="copyright">
  <p>Developed by Keaven Anderson. Site built with pkgdown 1.6.1.
  </p>
  <p>Copyright &copy; Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.</p>
</div>

      </footer>
   </div>

  


  </body>
</html>


